Review



lympholyte h cell separation medium  (Cedarlane)


Bioz Verified Symbol Cedarlane is a verified supplier
Bioz Manufacturer Symbol Cedarlane manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Cedarlane lympholyte h cell separation medium
    Lympholyte H Cell Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 95/100, based on 180 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/Lympholyte%C2%AE-H+Cell+Separation+Media+(Isolation+of+lymphocytes+from+Human+peripheral+blood)%2C+1%2E0770+%C2%B1+0%2E001+g%2Fml+%4025%C2%B0C/med_rxiv__64898__2026__03__12__26348144-59-7-12
    Average 95 stars, based on 180 article reviews
    lympholyte h cell separation medium - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Gradient Centrifugation:

    Article Title: Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
    Article Snippet: .. PBMCs were separated from other blood components by density gradient centrifugation using Lympholyte separation medium, and CD14+ PBMC were enriched by using the MiniMACS system according to the manufacturers’ instructions (Cedarlane, Burlington, ON, Canada; Miltenyi Biotec Inc., San Diego, CA, USA). ..

    Article Title: Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan.
    Article Snippet: .. PBMCs were separated from other blood components by density gradient centrifugation using Lympholyte separation medium, and CD14+ PBMC were enriched by using the MiniMACS system according to the manufacturers’ instructions (Cedarlane, Burlington, ON, Canada; Miltenyi Biotec Inc., San Diego, CA, USA). ..

    other:

    Article Title: Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
    Article Snippet: Peripheral blood mononuclear cells (PBMC) were separated on lympholyte separation medium (Cedarlane, Hornby, Ontario, CA) and washed twice in PBS at 1500 RPM for 10 min; viable leukocytes were determined using a TC 20 Automated Cell Counter (Biorad Hercules, CA, USA).

    Article Title: Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients
    Article Snippet: Peripheral blood mononuclear cells (PBMC) were separated on lympholyte separation medium (Cedarlane, Hornby, ON, Canada) and washed twice in PBS at 2000× g for 10 min; viable leukocytes were determined using a TC20 Automated Cell Counter (Biorad Hercules, CA, USA).

    Single Cell:

    Article Title: Mitochondrial Calcium Uniporter Affects Neutrophil Bactericidal Activity during Staphylococcus aureus Infection
    Article Snippet: .. Single-cell suspensions of bone marrow were subjected to density centrifugation to obtain mononuclear cells using Lympholyte separation medium (Cedarlane Laboratories). ..

    Centrifugation:

    Article Title: Mitochondrial Calcium Uniporter Affects Neutrophil Bactericidal Activity during Staphylococcus aureus Infection
    Article Snippet: .. Single-cell suspensions of bone marrow were subjected to density centrifugation to obtain mononuclear cells using Lympholyte separation medium (Cedarlane Laboratories). ..

    Isolation:

    Article Title: A Staphylococcus aureus Virulence Inhibitor Identified by SaeRS Refactoring and Screening in Bacillus subtilis .
    Article Snippet: Bacteria utilize two-component system (TCS) signal transduction pathways to sense environmental and physiological stimuli and mount appropriate responses.. In opportunistic pathogens such as Staphylococcus aureus, TCSs activate virulence programs in response to host defense systems.. Due to their critical role in pathogenesis, TCSs are important targets for antivirulence drug discovery campaigns.

    Cell Culture:

    Article Title: A Staphylococcus aureus Virulence Inhibitor Identified by SaeRS Refactoring and Screening in Bacillus subtilis .
    Article Snippet: Bacteria utilize two-component system (TCS) signal transduction pathways to sense environmental and physiological stimuli and mount appropriate responses.. In opportunistic pathogens such as Staphylococcus aureus, TCSs activate virulence programs in response to host defense systems.. Due to their critical role in pathogenesis, TCSs are important targets for antivirulence drug discovery campaigns.



    Similar Products

    95
    Cedarlane lympholyte h cell separation medium
    Lympholyte H Cell Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/Lympholyte%C2%AE-H+Cell+Separation+Media+(Isolation+of+lymphocytes+from+Human+peripheral+blood)%2C+1%2E0770+%C2%B1+0%2E001+g%2Fml+%4025%C2%B0C/med_rxiv__64898__2026__03__12__26348144-59-7-12
    Average 95 stars, based on 1 article reviews
    lympholyte h cell separation medium - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Cedarlane lympholyte®- mammal density separation medium
    Lympholyte® Mammal Density Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholyte+m+gradient/pm40578556-198-15-20
    Average 90 stars, based on 1 article reviews
    lympholyte®- mammal density separation medium - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cedarlane lympholyte-mammal cell separation medium
    Lympholyte Mammal Cell Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholyte+m+gradient/pm40499765-282-5-4
    Average 90 stars, based on 1 article reviews
    lympholyte-mammal cell separation medium - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cedarlane neutrophil isolation medium lympholyte-poly cell separation media
    (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, * p < 0.05 and ** p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β –/– mouse, n = 8 mice, and all other conditions , n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post- L. major infection (Wilcoxon, * p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4 + , and CD8 + cells) in infected ear skin (Wilcoxon, * p < 0.05, ** p < 0.01, and *** p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment , IL-1β –/– mouse, n = 8 mice and all other conditions , n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus . (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Neutrophil Isolation Medium Lympholyte Poly Cell Separation Media, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholyte+poly+isolation+medium/pmc12175678-57-0-8
    Average 90 stars, based on 1 article reviews
    neutrophil isolation medium lympholyte-poly cell separation media - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    EuroClone lympholyte cell separation medium
    (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, * p < 0.05 and ** p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β –/– mouse, n = 8 mice, and all other conditions , n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post- L. major infection (Wilcoxon, * p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4 + , and CD8 + cells) in infected ear skin (Wilcoxon, * p < 0.05, ** p < 0.01, and *** p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment , IL-1β –/– mouse, n = 8 mice and all other conditions , n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus . (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Lympholyte Cell Separation Medium, supplied by EuroClone, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholite+h/pmc12089405-180-28-35
    Average 90 stars, based on 1 article reviews
    lympholyte cell separation medium - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Cedarlane lympholyte mamma density gradient medium
    (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, * p < 0.05 and ** p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β –/– mouse, n = 8 mice, and all other conditions , n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post- L. major infection (Wilcoxon, * p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4 + , and CD8 + cells) in infected ear skin (Wilcoxon, * p < 0.05, ** p < 0.01, and *** p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment , IL-1β –/– mouse, n = 8 mice and all other conditions , n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus . (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Lympholyte Mamma Density Gradient Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/Lympholyte%C2%AE-M+Cell+Separation+Media+(Isolation+of+lymphocytes+from+Mouse+lymphoid+tissue)%2C+1%2E875+%C2%B1+0%2E001+g%2Fml+%4025%C2%B0C/pmc12111189-73-8-14
    Average 95 stars, based on 1 article reviews
    lympholyte mamma density gradient medium - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Cedarlane lympholyte®-m density separation medium
    (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, * p < 0.05 and ** p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β –/– mouse, n = 8 mice, and all other conditions , n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post- L. major infection (Wilcoxon, * p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4 + , and CD8 + cells) in infected ear skin (Wilcoxon, * p < 0.05, ** p < 0.01, and *** p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment , IL-1β –/– mouse, n = 8 mice and all other conditions , n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus . (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Lympholyte® M Density Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholyte+m+gradient/pmc12078306-91-13-17
    Average 90 stars, based on 1 article reviews
    lympholyte®-m density separation medium - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Cedarlane neutrophil isolation medium
    Figure 2. S. aureus triggers IL-1β to establish early inflammation and pathology during an L. major infection (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, *p < 0.05 and **p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice, and all other conditions, n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post-L. major infection (Wilcoxon, *p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4+, and CD8+ cells) in infected ear skin (Wilcoxon, *p < 0.05, **p < 0.01, and ***p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice and all other conditions, n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus. (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Neutrophil Isolation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/Lympholyte%C2%AE-poly+Cell+Separation+Media+(Isolation+of+PMNs+from+Human+peripheral+blood)%2C+1%2E113+%C2%B1+0%2E001+g%2Fml+%4025%C2%B0C/pm40293920-205-70-77
    Average 93 stars, based on 1 article reviews
    neutrophil isolation medium - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Cedarlane lympholyte separation medium
    Figure 2. S. aureus triggers IL-1β to establish early inflammation and pathology during an L. major infection (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, *p < 0.05 and **p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice, and all other conditions, n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post-L. major infection (Wilcoxon, *p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4+, and CD8+ cells) in infected ear skin (Wilcoxon, *p < 0.05, **p < 0.01, and ***p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice and all other conditions, n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus. (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Lympholyte Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholyte+m+gradient/pm40170243-225-5-8
    Average 90 stars, based on 1 article reviews
    lympholyte separation medium - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cedarlane lympholyte poly separation medium
    Figure 2. S. aureus triggers IL-1β to establish early inflammation and pathology during an L. major infection (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, *p < 0.05 and **p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice, and all other conditions, n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post-L. major infection (Wilcoxon, *p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4+, and CD8+ cells) in infected ear skin (Wilcoxon, *p < 0.05, **p < 0.01, and ***p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice and all other conditions, n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus. (E) Pie chart showing percentage of IL-1β+ cells that co-stain with <t>neutrophils,</t> macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.
    Lympholyte Poly Separation Medium, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lympholyte+separation+medium/lympholyte+m+gradient/pm40278516-57-14-18
    Average 90 stars, based on 1 article reviews
    lympholyte poly separation medium - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, * p < 0.05 and ** p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β –/– mouse, n = 8 mice, and all other conditions , n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post- L. major infection (Wilcoxon, * p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4 + , and CD8 + cells) in infected ear skin (Wilcoxon, * p < 0.05, ** p < 0.01, and *** p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment , IL-1β –/– mouse, n = 8 mice and all other conditions , n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus . (E) Pie chart showing percentage of IL-1β+ cells that co-stain with neutrophils, macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.

    Journal: Cell reports

    Article Title: Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β

    doi: 10.1016/j.celrep.2025.115624

    Figure Lengend Snippet: (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, * p < 0.05 and ** p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β –/– mouse, n = 8 mice, and all other conditions , n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post- L. major infection (Wilcoxon, * p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4 + , and CD8 + cells) in infected ear skin (Wilcoxon, * p < 0.05, ** p < 0.01, and *** p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment , IL-1β –/– mouse, n = 8 mice and all other conditions , n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus . (E) Pie chart showing percentage of IL-1β+ cells that co-stain with neutrophils, macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.

    Article Snippet: Neutrophil isolation medium (Lympholyte-poly cell separation media) , Cedarlane , Cat#CL5070.

    Techniques: Infection, Staining

    (A) Schematic outlining the study design of sample collection from patients with L. braziliensis infections. (B) Gene expression of IL-1β in lesion biopsies with an S. aureus -dominant or heterogeneous microbiome profile (Wilcoxon, ** p < 0.01). (C) Relative neutrophils in lesion biopsies as determined by cell estimation (XCell) (Wilcoxon, * p < 0.05). (D) GO pathway analysis comparing lesion biopsies with S. aureus dominance or a heterogeneous microbiome (Fisher’s one-tailed test with Benjamini-Hochberg adjustment, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001).

    Journal: Cell reports

    Article Title: Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β

    doi: 10.1016/j.celrep.2025.115624

    Figure Lengend Snippet: (A) Schematic outlining the study design of sample collection from patients with L. braziliensis infections. (B) Gene expression of IL-1β in lesion biopsies with an S. aureus -dominant or heterogeneous microbiome profile (Wilcoxon, ** p < 0.01). (C) Relative neutrophils in lesion biopsies as determined by cell estimation (XCell) (Wilcoxon, * p < 0.05). (D) GO pathway analysis comparing lesion biopsies with S. aureus dominance or a heterogeneous microbiome (Fisher’s one-tailed test with Benjamini-Hochberg adjustment, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001).

    Article Snippet: Neutrophil isolation medium (Lympholyte-poly cell separation media) , Cedarlane , Cat#CL5070.

    Techniques: Gene Expression, One-tailed Test

    (A) Schematic of bacterial swab extraction and isolate identification by MALDI-TOF. (B) Quantification of the frequency of bacterial species recovered from 44 human cutaneous leishmaniasis lesions. Each species is only counted once per lesion. (C) Phylogenetic tree of S. aureus clinical isolates and reference genomes. Layered onto the tree is each isolate’s methicillin resistance status and clonal complex. (D) ELISA quantifying levels of IL-1β recovered from mouse and human neutrophils infected with CLSA2 and CLSA50 strains (Wilcoxon, *** p < 0.001). (E) Bacterial survival of CLSA2 and CLSA50 in response to infection of human and mouse neutrophils for 1 h (paired t test, * p < 0.05). n = 4 human donors; n = 5 mice.

    Journal: Cell reports

    Article Title: Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β

    doi: 10.1016/j.celrep.2025.115624

    Figure Lengend Snippet: (A) Schematic of bacterial swab extraction and isolate identification by MALDI-TOF. (B) Quantification of the frequency of bacterial species recovered from 44 human cutaneous leishmaniasis lesions. Each species is only counted once per lesion. (C) Phylogenetic tree of S. aureus clinical isolates and reference genomes. Layered onto the tree is each isolate’s methicillin resistance status and clonal complex. (D) ELISA quantifying levels of IL-1β recovered from mouse and human neutrophils infected with CLSA2 and CLSA50 strains (Wilcoxon, *** p < 0.001). (E) Bacterial survival of CLSA2 and CLSA50 in response to infection of human and mouse neutrophils for 1 h (paired t test, * p < 0.05). n = 4 human donors; n = 5 mice.

    Article Snippet: Neutrophil isolation medium (Lympholyte-poly cell separation media) , Cedarlane , Cat#CL5070.

    Techniques: Extraction, Enzyme-linked Immunosorbent Assay, Infection

    Figure 2. S. aureus triggers IL-1β to establish early inflammation and pathology during an L. major infection (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, *p < 0.05 and **p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice, and all other conditions, n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post-L. major infection (Wilcoxon, *p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4+, and CD8+ cells) in infected ear skin (Wilcoxon, *p < 0.05, **p < 0.01, and ***p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice and all other conditions, n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus. (E) Pie chart showing percentage of IL-1β+ cells that co-stain with neutrophils, macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.

    Journal: Cell reports

    Article Title: Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β.

    doi: 10.1016/j.celrep.2025.115624

    Figure Lengend Snippet: Figure 2. S. aureus triggers IL-1β to establish early inflammation and pathology during an L. major infection (A) Pathology scoring and ear thickness measurements in mice uninfected or infected with either L. major alone or with both S. aureus colonization and L. major infection (Wilcoxon, *p < 0.05 and **p < 0.01; mean ± SD representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice, and all other conditions, n = 6 mice). (B) Bacterial burden (CFUs) and L. major parasite burden at day 7 post-L. major infection (Wilcoxon, *p < 0.05). (C) Flow cytometric analysis of immune cell recruitment (Ly6G+, CD4+, and CD8+ cells) in infected ear skin (Wilcoxon, *p < 0.05, **p < 0.01, and ***p < 0.001; mean representative of 2 experiments; L. major-S. aureus treatment, IL-1β−/−mouse, n = 8 mice and all other conditions, n = 6 mice). (D) Percentage of immune cells recruited to the site of infection in mice infected with L. major with and without colonization of S. aureus. (E) Pie chart showing percentage of IL-1β+ cells that co-stain with neutrophils, macrophages, monocytes, and unidentified cells at 7 days post-infection. Based on flow cytometric data.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Staphylococcus aureus CLSA51 this paper CLSA51 Staphylococcus aureus CLSA52 this paper CLSA52 Staphylococcus aureus CLSA54 this paper CLSA54 Staphylococcus aureus CLSA56 this paper CLSA56 Staphylococcus aureus CLSA57 this paper CLSA57 Staphylococcus aureus CLSA62 this paper CLSA62 Chemicals, peptides, and recombinant proteins blood agar Remel Cat#R01201 Tryptic soy broth, Difco Fisher Scientific Cat#DF0370 RPMI 1640 Invitrogen Cat#11875085 Liberase TL Roche Cat#540102000 Dnase I Sigma Aldrich Cat#DN25 Neutrophil isolation medium (Lympholytepoly cell separation media) Cedarlane Cat#CL5070 Red blood cell lysis buffer Roche Cat#11814389001 Trizol Ambion Inc Cat#15596026 BBL CHROMagar Staph aureus BD Cat#214982 Saponin 10% Sigma Cat#59700 Chocolate agar Remel Cat#R08240 Microbank microbial storage tubes Pro-lab Cat#PL.170C/M Schneiders Drosophila medium GIBCO Cat#21720024 Fetal Bovine Serum Avantor Cat#89510186 L-glutamine 200mM Sigma Cat#G7513 Ficoll 400 Sigma Cat#F2637 10% Rat IgG Sigma Cat#18015 Formaldehyde Aqueous Solution Electron Microscopy Sciences Cat#15700 Leukocyte Activation Cocktail BD Biosciences Cat#550583 Covaris milliTube 2mL Covaris Cat#520132 Covaris tissueTUBE TT05M Covaris Cat#520139 Percoll Cytiva Cat#17089101 ACK lysing buffer Quality Biological Cat#118156721 Penicillin-Streptomycin Sigma Cat#P0781 Critical commercial assays Quick DNA mini-prep plus kit Zymo research Cat#D4069 DNAase digestion Qiagen Cat#79294 2100 Bioanalyzer and Eukaryotic Total RNA 6000 Pico Kit Agilent Cat#5067-1513 Qubit by RNA Broad Range assay Invitrogen Cat#Q10210 Illumina Stranded Total RNA Prep with Ribo-Zero Plus Illumina Cat#20040525 ELISA MAXTM Deluxe Set Human IL-1β BioLegend Cat#437004 Deposited data Whole genome sequences of 30 S aureus clinical isolates this paper NCBI Bioproject: PRJNA922957 Murine RNAseq data this paper NCBI Bioproject: PRJNA1212200 Human RNAseq data Farias Amorim et al.9 NCBI Bioproject: PRJNA885131 Experimental models: Organisms/strains C57BL6/J Mice The Jackson Laboratory Cat#000664 C57BL6/J IL-1b− /− Mice Dr.

    Techniques: Infection, Staining

    Figure 3. Pro-inflammatory pathways associated with IL-1β, cytotoxicity, cell death, and neutrophil recruitment are enriched in human Leishmania infections complicated by S. aureus (A) Schematic outlining the study design of sample collection from patients with L. braziliensis infections. (B) Gene expression of IL-1β in lesion biopsies with an S. aureus-dominant or heterogeneous microbiome profile (Wilcoxon, **p < 0.01). (C) Relative neutrophils in lesion biopsies as determined by cell estimation (XCell) (Wilcoxon, *p < 0.05). (D) GO pathway analysis comparing lesion biopsies with S. aureus dominance or a heterogeneous microbiome (Fisher’s one-tailed test with Benjamini-Hochberg adjustment, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001).

    Journal: Cell reports

    Article Title: Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β.

    doi: 10.1016/j.celrep.2025.115624

    Figure Lengend Snippet: Figure 3. Pro-inflammatory pathways associated with IL-1β, cytotoxicity, cell death, and neutrophil recruitment are enriched in human Leishmania infections complicated by S. aureus (A) Schematic outlining the study design of sample collection from patients with L. braziliensis infections. (B) Gene expression of IL-1β in lesion biopsies with an S. aureus-dominant or heterogeneous microbiome profile (Wilcoxon, **p < 0.01). (C) Relative neutrophils in lesion biopsies as determined by cell estimation (XCell) (Wilcoxon, *p < 0.05). (D) GO pathway analysis comparing lesion biopsies with S. aureus dominance or a heterogeneous microbiome (Fisher’s one-tailed test with Benjamini-Hochberg adjustment, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001).

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Staphylococcus aureus CLSA51 this paper CLSA51 Staphylococcus aureus CLSA52 this paper CLSA52 Staphylococcus aureus CLSA54 this paper CLSA54 Staphylococcus aureus CLSA56 this paper CLSA56 Staphylococcus aureus CLSA57 this paper CLSA57 Staphylococcus aureus CLSA62 this paper CLSA62 Chemicals, peptides, and recombinant proteins blood agar Remel Cat#R01201 Tryptic soy broth, Difco Fisher Scientific Cat#DF0370 RPMI 1640 Invitrogen Cat#11875085 Liberase TL Roche Cat#540102000 Dnase I Sigma Aldrich Cat#DN25 Neutrophil isolation medium (Lympholytepoly cell separation media) Cedarlane Cat#CL5070 Red blood cell lysis buffer Roche Cat#11814389001 Trizol Ambion Inc Cat#15596026 BBL CHROMagar Staph aureus BD Cat#214982 Saponin 10% Sigma Cat#59700 Chocolate agar Remel Cat#R08240 Microbank microbial storage tubes Pro-lab Cat#PL.170C/M Schneiders Drosophila medium GIBCO Cat#21720024 Fetal Bovine Serum Avantor Cat#89510186 L-glutamine 200mM Sigma Cat#G7513 Ficoll 400 Sigma Cat#F2637 10% Rat IgG Sigma Cat#18015 Formaldehyde Aqueous Solution Electron Microscopy Sciences Cat#15700 Leukocyte Activation Cocktail BD Biosciences Cat#550583 Covaris milliTube 2mL Covaris Cat#520132 Covaris tissueTUBE TT05M Covaris Cat#520139 Percoll Cytiva Cat#17089101 ACK lysing buffer Quality Biological Cat#118156721 Penicillin-Streptomycin Sigma Cat#P0781 Critical commercial assays Quick DNA mini-prep plus kit Zymo research Cat#D4069 DNAase digestion Qiagen Cat#79294 2100 Bioanalyzer and Eukaryotic Total RNA 6000 Pico Kit Agilent Cat#5067-1513 Qubit by RNA Broad Range assay Invitrogen Cat#Q10210 Illumina Stranded Total RNA Prep with Ribo-Zero Plus Illumina Cat#20040525 ELISA MAXTM Deluxe Set Human IL-1β BioLegend Cat#437004 Deposited data Whole genome sequences of 30 S aureus clinical isolates this paper NCBI Bioproject: PRJNA922957 Murine RNAseq data this paper NCBI Bioproject: PRJNA1212200 Human RNAseq data Farias Amorim et al.9 NCBI Bioproject: PRJNA885131 Experimental models: Organisms/strains C57BL6/J Mice The Jackson Laboratory Cat#000664 C57BL6/J IL-1b− /− Mice Dr.

    Techniques: Gene Expression, One-tailed Test

    Figure 4. S. aureus isolates cultured from human cutaneous leishmaniasis lesions are phylogenetically and phenotypically diverse (A) Schematic of bacterial swab extraction and isolate identification by MALDI-TOF. (B) Quantification of the frequency of bacterial species recovered from 44 human cutaneous leishmaniasis lesions. Each species is only counted once per lesion. (C) Phylogenetic tree of S. aureus clinical isolates and reference genomes. Layered onto the tree is each isolate’s methicillin resistance status and clonal complex. (D) ELISA quantifying levels of IL-1β recovered from mouse and human neutrophils infected with CLSA2 and CLSA50 strains (Wilcoxon, ***p < 0.001). (E) Bacterial survival of CLSA2 and CLSA50 in response to infection of human and mouse neutrophils for 1 h (paired t test, *p < 0.05). n = 4 human donors; n = 5 mice.

    Journal: Cell reports

    Article Title: Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β.

    doi: 10.1016/j.celrep.2025.115624

    Figure Lengend Snippet: Figure 4. S. aureus isolates cultured from human cutaneous leishmaniasis lesions are phylogenetically and phenotypically diverse (A) Schematic of bacterial swab extraction and isolate identification by MALDI-TOF. (B) Quantification of the frequency of bacterial species recovered from 44 human cutaneous leishmaniasis lesions. Each species is only counted once per lesion. (C) Phylogenetic tree of S. aureus clinical isolates and reference genomes. Layered onto the tree is each isolate’s methicillin resistance status and clonal complex. (D) ELISA quantifying levels of IL-1β recovered from mouse and human neutrophils infected with CLSA2 and CLSA50 strains (Wilcoxon, ***p < 0.001). (E) Bacterial survival of CLSA2 and CLSA50 in response to infection of human and mouse neutrophils for 1 h (paired t test, *p < 0.05). n = 4 human donors; n = 5 mice.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Staphylococcus aureus CLSA51 this paper CLSA51 Staphylococcus aureus CLSA52 this paper CLSA52 Staphylococcus aureus CLSA54 this paper CLSA54 Staphylococcus aureus CLSA56 this paper CLSA56 Staphylococcus aureus CLSA57 this paper CLSA57 Staphylococcus aureus CLSA62 this paper CLSA62 Chemicals, peptides, and recombinant proteins blood agar Remel Cat#R01201 Tryptic soy broth, Difco Fisher Scientific Cat#DF0370 RPMI 1640 Invitrogen Cat#11875085 Liberase TL Roche Cat#540102000 Dnase I Sigma Aldrich Cat#DN25 Neutrophil isolation medium (Lympholytepoly cell separation media) Cedarlane Cat#CL5070 Red blood cell lysis buffer Roche Cat#11814389001 Trizol Ambion Inc Cat#15596026 BBL CHROMagar Staph aureus BD Cat#214982 Saponin 10% Sigma Cat#59700 Chocolate agar Remel Cat#R08240 Microbank microbial storage tubes Pro-lab Cat#PL.170C/M Schneiders Drosophila medium GIBCO Cat#21720024 Fetal Bovine Serum Avantor Cat#89510186 L-glutamine 200mM Sigma Cat#G7513 Ficoll 400 Sigma Cat#F2637 10% Rat IgG Sigma Cat#18015 Formaldehyde Aqueous Solution Electron Microscopy Sciences Cat#15700 Leukocyte Activation Cocktail BD Biosciences Cat#550583 Covaris milliTube 2mL Covaris Cat#520132 Covaris tissueTUBE TT05M Covaris Cat#520139 Percoll Cytiva Cat#17089101 ACK lysing buffer Quality Biological Cat#118156721 Penicillin-Streptomycin Sigma Cat#P0781 Critical commercial assays Quick DNA mini-prep plus kit Zymo research Cat#D4069 DNAase digestion Qiagen Cat#79294 2100 Bioanalyzer and Eukaryotic Total RNA 6000 Pico Kit Agilent Cat#5067-1513 Qubit by RNA Broad Range assay Invitrogen Cat#Q10210 Illumina Stranded Total RNA Prep with Ribo-Zero Plus Illumina Cat#20040525 ELISA MAXTM Deluxe Set Human IL-1β BioLegend Cat#437004 Deposited data Whole genome sequences of 30 S aureus clinical isolates this paper NCBI Bioproject: PRJNA922957 Murine RNAseq data this paper NCBI Bioproject: PRJNA1212200 Human RNAseq data Farias Amorim et al.9 NCBI Bioproject: PRJNA885131 Experimental models: Organisms/strains C57BL6/J Mice The Jackson Laboratory Cat#000664 C57BL6/J IL-1b− /− Mice Dr.

    Techniques: Cell Culture, Extraction, Enzyme-linked Immunosorbent Assay, Infection